… GI symptoms in patients with COVID-19 infection, we conducted an updated systematic …
the prevalence of GI symptoms in patients with COVID-19 infection and determine whether …

… the prevalence of GI symptoms, elevated liver enzymes and mortality of patients with COVID-19.
… We thus conducted a systematic review of published GI symptoms and elevated liver …

… of gastrointestinal symptoms and mortality of COVID-19 … between gastrointestinal symptoms
and COVID-19 mortality. … observed in patients with COVID-19, with a prevalence of up …

… more prevalence of GI manifestations in severe COVID-19 patients. … GI manifestations as a
prognostic factor such as mortality. Our … risk of mortality in patients with GI manifestations if we …

… features of COVID-19 and the prevalence of gastrointestinal findings in infected patients, and
… We have provided a pooled estimate of the prevalence of gastrointestinal symptoms and …

… Interestingly, this meta-analysis showed that the prevalence of GI symptoms was higher in
patients … , as COVID-19 patients who manifest GI symptoms may require closer monitoring. …

… and clinical data of patients with COVID-19, the prevalence of GI symptoms, and the serum
… from 15 studies noted that acute liver injury was associated with increased mortality (RR = …

… (a) global prevalence of prolonged GI symptoms including nausea, … of COVID-19 severity
with the presence of prolonged GI … prolonged GI symptoms observed in patients with COVID-19 …

… Mortality among patients with GI symptoms was similar to the overall mortality. However, most
… In this study, we were able to examine the incidence of diarrheal symptoms of COVID-19 in …

… prevalence of diarrhea (13%) and nausea/vomiting (9.5%). We believe that the reported
prevalence of … disease, based on our meta-analysis results, COVID-19 patients with diarrhea …